Intentar ORO - Gratis
Think global, act local - Romaco's approach to the Indian pharma market
Express Pharma
|December 2024
The Indian pharmaceutical market is dynamic and increasingly international, which is reflected in trade fairs such as CPHI & PMEC India. Jens Torkel, MD, Romaco Group, a leading international supplier of machines and integrated system solutions for the development, manufacture and packaging of pharmaceuticals, and Sanjeev A. Nimkar, MD, Romaco India, Romaco's Sales & Service Centre based in Mumbai, underline the importance of the CPHI & PMEC and explain how machine manufacturers are meeting the requirements of pharma companies in India
-

What industry trends are you noticing at CPHI & PMEC this year, and how is your company positioned to address them?
Torkel: Two of the major trends are increased digitalisation and more sustainability initiatives, particularly, but not exclusively, with regard to reducing emissions and saving energy.
Romaco is very well positioned for this development because we have been putting sustainability at the heart of our machine design, production and business processes in general for quite some time. As a result of this early implementation, our machines are ready to help the pharmaceutical industry to produce more sustainably for example, by reducing energy and material consumption, shortening process times and lowering CO2 emissions. For our commitment, we recently received a gold medal in the EcoVadis Sustainability Ranking, putting us in the top two per cent of rated companies.
Nimkar: What this trend towards sustainability also implies, is the need for more effective and efficient production, which is a major topic for Indian contract manufacturers, for example. The beauty of it is that sustainability, effectiveness and efficiency go hand in hand in pharma production when solutions address aspects such as process times or resource consumption.
One of our latest innovations in this area are energy recovery systems for drum coaters and fluid bed processers, that allow to cut the consumption of heat energy by up to 50 per cent in tablet coating and up to 70 per cent with fluid bed processors, depending on the product and the process.

Esta historia es de la edición December 2024 de Express Pharma.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Express Pharma

Express Pharma
Flexotherm Heating Tapes & Cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
October 2025

Express Pharma
DRIVING INDIA'S INNOVATION EDGE
Pharma leaders come together to highlight Bengaluru's R&D strength, tech ecosystem, and talent pool to power India Pharma Inc's shift from generics to innovation and global leadership
16 mins
October 2025

Express Pharma
Al compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging Al across nearly every aspect of commercialisation, from market forecasting and personalised marketing to dynamic pricing and beyond. In this article, Neha Aathavale takes the pulse of the industry to explore who is taking note and how companies are beginning to put Al into action in their commercial operations
7 mins
October 2025

Express Pharma
PRIME NEO: New age doors from Gandhi Automation
Gandhi Automations presents the multi-composites, high-performance door PRIME NEO for clean environments. Complete Washable, Greater Sealing and Pressure Resistant.
1 mins
October 2025

Express Pharma
Unani Medicine: At crossroads of tradition and modernity
Manufacturers, academic institutions and research councils are working together to elevate Unani medicine through clinical validation and policy alignment with international standards, finds Swati Rana
7 mins
October 2025

Express Pharma
Single-Use Technologies in Biologics Manufacturing: Benefits, Challenges, and Growing Demand
The biopharmaceutical industry is increasingly adopting single-use technology (SUT) to achieve flexibility, cost efficiency, and faster time-to-market. Compared with stainless steel systems, SUT reduces capital investment, eliminates cleaning and sterilization steps, lowers contamination risk, and shortens production timelines.
1 min
October 2025

Express Pharma
Sustainable packaging with Romaco and Liveo Research
Recycable blister packs
3 mins
October 2025

Express Pharma
With India soon to be three times the population of the EU, it makes perfect sense to have manufacturing here
As part of Sweden's Focus Asia programme, a high-level SME delegation recently visited India to strengthen bilateral ties and explore collaborations across sectors including pharma, biotech and others. Building on the momentum of the \"Time for Sweden\" event, the visit underscored Sweden's commitment to innovation, sustainability, and co-creation with India. Among the delegation was Emil Alexander Byström, CEO of SpinChem AB, who in an interaction with Kalyani Sharma shared his insights on how advanced Swedish technologies like biocatalysis and the company's patented Rotating Bed Reactor (RBR) can accelerate India's pharma and biotech innovation journey while supporting sustainable growth.
3 mins
October 2025

Express Pharma
Cell therapy's next chapter: Industry embraces in-vivo innovation
Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that cell therapy is entering a bold new phase in 2025 as the industry shifts from complex, lab-based ex vivo CAR-T to faster, more accessible in vivo CAR-T innovations. This approach promises to expand access, lower costs, and potentially tackle solid tumors and autoimmune diseases
4 mins
October 2025

Express Pharma
Research misconduct ...can delay meaningful and reliable discoveries
Dr Gráinne McNamara, Research Integrity/Publication Ethics Manager, S. Karger AG explores how research misconduct, peer review fraud slow down pharma research. Of particular concern to India is the fact that India-based researchers constitute 5 per cent of articles in life sciences retracted between 1976-2023. India-based researchers also have one of the highest rates of retraction relative to the overall publication output. Over an email exchange with Viveka Roychowdhury, she details how publishers are now deploying AI tools, some of which contributed to the problem in the first place, to detect and avert fraudulent research submissions
6 mins
October 2025
Listen
Translate
Change font size